Michael S. Seaman

Beth Israel Deaconess Medical Center

Papers

1

Total Citations

46

H-Index

1

About

Michael S. Seaman is a leading immunologist whose research focuses on the molecular evolution of broadly neutralizing antibodies against HIV-1, with a particular emphasis on unconventional antibody formats from camelids. His major contributions include pioneering work on eliciting heavy chain-only antibodies (HCAb) in llamas, demonstrating that these unique molecules can achieve remarkable breadth and potency against the CD4-binding site of HIV-1—a feat that traditional immunization strategies in humans and animals had failed to accomplish. This seminal 2014 study, cited 46 times, provided critical insights into how the immune system can be guided to produce broadly neutralizing sera, offering a novel pathway for HIV vaccine design. Seaman’s work has advanced our understanding of antibody evolution and the structural requirements for neutralization, influencing subsequent efforts in vaccine immunogen design. His research stands as a cornerstone in the quest for an effective HIV vaccine, highlighting the power of comparative immunology in tackling one of medicine’s greatest challenges.

Research Focus

Key Achievements

1
H-Index
1
Papers
46
Total Citations
46
Avg Citations/Paper
🏆 Most Cited Paper
Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1
46 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Beth Israel Deaconess Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago